Page 19 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 19
GENERAL INTRODUCTION 1
31. El-Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA. Association of anti- modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J Rheumatol 2011 May;38(5):828- 34.
32. BastienM,PoirierP,LemieuxI,DespresJP.Overviewofepidemiologyandcontributionof obesity to cardiovascular disease. Prog Cardiovasc Dis 2014 Jan;56(4):369-81.
33. LahiriM,LubenRN,MorganC,BunnDK,MarshallT,LuntM,etal.Usinglifestylefactors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register- -the EPIC-2-NOAR Study). Ann Rheum Dis 2014 Jan;73(1):219-26.
34. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005 Nov 5;366(9497):1640-9.
35. Book C, Karlsson MK, Akesson K, Jacobsson LT. Early rheumatoid arthritis and body composition. Rheumatology (Oxford) 2009 Sep;48(9):1128-32.
36. BookC,KarlssonMK,NilssonJA,AkessonK,JacobssonLT.Changesinbodycomposition after 2 years with rheumatoid arthritis. Scand J Rheumatol 2011 Mar;40(2):95-100.
37. Dao HH, Do QT, Sakamoto J. Abnormal body composition phenotypes in Vietnamese
women with early rheumatoid arthritis. Rheumatology (Oxford) 2011 Jul;50(7):1250-8.
38. DesseinPH,SolomonA,HollanI.Metabolicabnormalitiesinpatientswithinflammatory
rheumatic diseases. Best Pract Res Clin Rheumatol 2016 Oct;30(5):901-15.
39. Andreoli A, Scalzo G, Masala S, Tarantino U, Guglielmi G. Body composition assessment
by dual-energy X-ray absorptiometry (DXA). Radiol Med 2009 Mar;114(2):286-300.
40. LazzeriniPE,AcampaM,CapecchiPL,HammoudM,MaffeiS,BisognoS,etal.Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med 2013 Jun;24(4):368-74.
41. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 2014
Sep;13(9):936-44.
42. Seferovic PM, Ristic AD, Maksimovic R, Simeunovic DS, Ristic GG, Radovanovic G, et al.
Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases.
Rheumatology (Oxford) 2006 Oct;45 Suppl 4:iv39-iv42.
43. KenigsbergDN,KhanalS,KowalskiM,KrishnanSC.ProlongationoftheQTcintervalisseen
uniformly during early transmural ischemia. J Am Coll Cardiol 2007 Mar 27;49(12):1299-
305.
44. Sordillo PP, Sordillo DC, Helson L. Review: The Prolonged QT Interval: Role of Pro-
inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1
Phosphate Pathways. In Vivo 2015 Nov;29(6):619-36.
45. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention
of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009 May 19;338:b1665.
17
